Conducts basic laboratory research using animal models, in vitro culture techniques, and highly sophisticated bench research technologies to increase knowledge of the processes that spark cell transformation into cancer and identify more ways to slow or stop cancer growth.
This is the first and largest affiliate of the University of Texas MD Anderson Cancer Center in Houston
and also a wholly owned subsidiary of Orlando Health. The center strives to “use every available resource to defeat cancer.” It is noted as an early adopter of advanced diagnostic and therapeutic procedures. The center was among the nation’s first to offer stereotactic interstitial brachytherapy, intensity modulated and image-guided intensity modulated radiation therapy, shaped beam surgery, and helical tomotherapy. It follows the same clinical practice guidelines in use at MD Anderson-Houston and routinely participates with that facility in clinical research trials originating from Houston.